Acción FBIOP FORTRESS BIOTECH, INC.
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas Fortress Biotech, Inc. Nasdaq

Acciones

FBIOP

US34960Q2084

Mercado cerrado - Nasdaq
Otros sitios de cotización
 22:00:00 17/05/2024 		Varia. Cinco días. Varia. 1 de enero.
16,67 USD +1,96 % Gráfico intradía de Fortress Biotech, Inc. +4,32 % +40,44 %
14/05 Fortress Biotech dice que se ha dosificado al primer paciente en el estudio de fase 2 de Triplex MT
14/05 Fortress Biotech anuncia la dosificación del primer paciente en un estudio multicéntrico de fase 2 de Triplex para el control del CMV en pacientes sometidos a trasplante de hígado CI

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
Fortress Biotech to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase
Fortress Biotech: Q1 Earnings Snapshot
Earnings Flash (FBIO) FORTRESS BIOTECH Posts Q1 Revenue $13M
Fortress Biotech Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
Journey Medical Corporation to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase
Fortress Biotech Says First Patient Dosed in Phase 2 Study of Triplex
Fortress Biotech Announces First Patient Dosed in Multi-Center Phase 2 Study of Triplex for Control of CMV in Patients Undergoing Liver Transplantation
Fortress Biotech Announces First Patient Dosed in Multi-Center Phase 2 Study of Triplex for Control of CMV in Patients Undergoing Liver Transplantation
Journey Medical Corporation Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
Journey Medical Corporation to Announce First Quarter 2024 Financial Results on May 13, 2024
Journey Medical Corporation Appoints Joseph Benesch as Chief Financial Officer
Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross Proceeds
Journey Medical Corporation to Present at the Planet MicroCap Showcase: Vegas 2024
Avenue Therapeutics Announces Reverse Stock Split
North American Morning Briefing : Powell Awaited -2-
Certain Warrants of Fortress Biotech, Inc. are subject to a Lock-Up Agreement Ending on 2-APR-2024.
Certain Options of Fortress Biotech, Inc. are subject to a Lock-Up Agreement Ending on 2-APR-2024.
Certain Common Stock of Fortress Biotech, Inc. are subject to a Lock-Up Agreement Ending on 2-APR-2024.
Fortress Biotech, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Fortress Biotech Reports 2023 Financial Results and Recent Corporate Highlights
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción FBIO
  4. Acción FBIOP
  5. Noticias Fortress Biotech, Inc.
  6. Otros idiomas